JamesBradleyThomasRPh

PubMed

• Phase I trial of motexafin gadolinium and doxorubicin in the treatment of advanced malignancies.
  Traynor, A.M., Thomas, J.P., Ramanathan, R.K., Mody, T.D., Alberti, D., Wilding, G., Bailey, H.H.> ;Invest New Drugs. 2011-04-01
• Cytotoxic Evaluation of 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone, 3-AP, in Peripheral Blood Lymphocytes of Patients with Refractory Solid Tumors using Electr...
  Kolesar, J.M., Sachidanandam, K., Schelman, W.R., Eickhoff, J., Holen, K.D., Traynor, A.M., Alberti, D.B., Thomas, J.P., Chitambar, C.R., Wilding, G., Antholine, W.E.> ;Exp Ther Med. 2011 1
• A phase II study of oxaliplatin, 5-fluorouracil, leucovorin, and high-dose capecitabine in patients with metastatic colorectal cancer.
  Lubner, S.J., Loconte, N.K., Holen, K.D., Schelman, W., Thomas, J.P., Jumonville, A., Eickhoff, J.C., Seo, S., Mulkerin, D.L.> ;Clin Colorectal Cancer. 2010 Jul
• I can see you better if I can hear you coming: action-consistent sounds facilitate the visual detection of human gait.
  Thomas, J.P., Shiffrar, M.> ;J Vis. 2010
• Electron paramagnetic resonance study of peripheral blood mononuclear cells from patients with refractory solid tumors treated with Triapine.
  Kolesar, J.M., Schelman, W.R., Geiger, P.G., Holen, K.D., Traynor, A.M., Alberti, D.B., Thomas, J.P., Chitambar, C.R., Wilding, G., Antholine, W.E.> ;J Inorg Biochem. 2008 Apr
• Biologic study of the effects of octreotide-LAR on growth hormone in unresectable and metastatic hepatocellular carcinoma.
  Attia, S., Holen, K.D., Thomas, J.P., Richie, K., Dzelak, T., Teeter, K., Warren, D., Bilger, A., Fine, J., Eickhoff, J., Drinkwater, N., Mulkerin, D., Morgan-Meadows, S.> ;Clin Adv Hematol Oncol. 2008 Jan
• Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803.
  Saltz, L.B., Niedzwiecki, D., Hollis, D., Goldberg, R.M., Hantel, A., Thomas, J.P., Fields, A.A., Mayer, R.J.> ;J Clin Oncol. 2007 Aug 10
• Phase I trial of weekly paclitaxel and BMS-214662 in patients with advanced solid tumors.
  Bailey, H.H., Alberti, D.B., Thomas, J.P., Mulkerin, D.L., Binger, K.A., Gottardis, M.M., Martell, R.E., Wilding, G.> ;Clin Cancer Res. 2007 Jun 15
• Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachythe...
  Kennedy, A., Nag, S., Salem, R., Murthy, R., McEwan, A.J., Nutting, C., Benson, A., Espat, J., Bilbao, J.I., Sharma, R.A., Thomas, J.P., Coldwell, D.> ;Int J Radiat Oncol Biol Phys. 2007 May 1
• Phase I trial of a monoclonal antibody specific for alphavbeta3 integrin (MEDI-522) in patients with advanced malignancies, including an assessment of effect on tumor ...
  McNeel, D.G., Eickhoff, J., Lee, F.T., King, D.M., Alberti, D., Thomas, J.P., Friedl, A., Kolesar, J., Marnocha, R., Volkman, J., Zhang, J., Hammershaimb, L., Zwiebel,...> ;Clin Cancer Res. 2005 Nov 1
• Frequency and phase contributions to the detection of temporal luminance modulation.
  Thomas, J.P., Knoblauch, K.> ;J Opt Soc Am A Opt Image Sci Vis. 2005 Oct
• A phase I and pharmacologic trial of two schedules of the proteasome inhibitor, PS-341 (bortezomib, velcade), in patients with advanced cancer.
  > ;Clin Cancer Res. 2005 May 1
• Gemcitabine, Paclitaxel, and piritrexim: a phase I study.
  Liu, G., Bailey, H.H., Arzoomanian, R.Z., Alberti, D., Binger, K., Volkman, J., Feierabend, C., Marnocha, R., Wilding, G., Thomas, J.P.> ;Am J Clin Oncol. 2003 Jun
• Phase I pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors.
  Thomas, J.P., Arzoomanian, R.Z., Alberti, D., Marnocha, R., Lee, F., Friedl, A., Tutsch, K., Dresen, A., Geiger, P., Pluda, J., Fogler, W., Schiller, J.H., Wilding, G.> ;J Clin Oncol. 2003 Jan 15
• Phase I study of eniluracil, oral 5-fluororacil and gemcitabine in patients with advanced malignancy.
  Morgan-Meadows, S., Thomas, J.P., Mulkerin, D., Berlin, J.D., Bailey, H., Binger, K., Volkman, J., Alberti, D., Feierabend, C., Marrocha, R., Arzoomanian, R.Z., Wildin...> ;Invest New Drugs. 2002 Nov
• Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology G...
  Berlin, J.D., Catalano, P., Thomas, J.P., Kugler, J.W., Haller, D.G., Benson, A.B.> ;J Clin Oncol. 2002 Aug 1
• Phase II trial of perillyl alcohol in patients with metastatic colorectal cancer.
  Meadows, S.M., Mulkerin, D., Berlin, J., Bailey, H., Kolesar, J., Warren, D., Thomas, J.P.> ;Int J Gastrointest Cancer. 2002
• Dual nonlinearities regulate contrast sensitivity in pattern discrimination tasks.
  Olzak, L. A., Thomas, J. P.> ;Vision Res. 2003 Jun
• Effects of nonspatial selective and divided visual attention on fMRI BOLD responses.
  Weerda, R., Vallines, I., Thomas, J. P., Rutschmann, R. M., Greenlee, M. W.> ;Exp Brain Res. 2006 Sep
• Factors affecting longevity of homograft valves used in right ventricular outflow tract reconstruction for congenital heart disease.
  Tweddell, J. S., Pelech, A. N., Frommelt, P. C., Mussatto, K. A., Wyman, J. D., Fedderly, R. T., Berger, S., Frommelt, M. A., Lewis, D. A., Friedberg, D. Z., Thomas, J...> ;Circulation. 2000 Nov 7
• Fixed-dose-rate gemcitabine in combination with oxaliplatin in patients with metastatic pancreatic cancer refractory to standard-dose-rate gemcitabine: a single-instit...
  Fortune, B. E., Li, X., Kosuri, K. V., Weatherby, L. M., Thomas, J. P., Bekaii-Saab, T. S.> ;Oncology. 2009
• Phase II study of gemcitabine in combination with docetaxel in patients with advanced pancreatic carcinoma (E1298). A trial of the eastern cooperative oncology group.
  Shepard, R. C., Levy, D. E., Berlin, J. D., Stuart, K., Harris, J. E., Aviles, V., Thomas, J. P., Benson, A. B.> ;Oncology. 2004
• Phase I clinical and pharmacokinetic trial of the cyclin-dependent kinase inhibitor flavopiridol.
  Thomas, J. P., Tutsch, K. D., Cleary, J. F., Bailey, H. H., Arzoomanian, R., Alberti, D., Simon, K., Feierabend, C., Binger, K., Marnocha, R., Dresen, A., Wilding, G.> ;Cancer Chemother Pharmacol. 2002 Dec
• A phase I trial of gemcitabine in combination with patupilone in patients with advanced solid tumors.
  Schelman, W., Morgan-Meadows, S., Bailey, H., Holen, K., Thomas, J. P., Eickhoff, J., Brandon, H., Oliver, K., Alberti, D., Wilding, G.> ;Cancer Chemother Pharmacol. 2008 Sep
• A phase II trial of gemcitabine, 5-fluorouracil and leucovorin in advanced esophageal carcinoma.
  Morgan-Meadows, S., Mulkerin, D., Berlin, J. D., Kim, K., Bailey, H., Saphner, T., Jumonville, A., Hansen, R., Ahuja, H., McFarland, T., Thomas, J. P.> ;Oncology. 2005
• Join now to see all